StocksMedium•28 September 2026•
1 min read
Addex Therapeutics Releases Q2 2026 Financial Results
Key Facts
1Addex Therapeutics released its Q2 2026 financial results and hosted an earnings call to discuss performance.
Addex Therapeutics released its Q2 2026 financial results. Benzinga reported that the company hosted an earnings conference call to discuss its performance and recent developments with investors.
The stock ADXN closed at $3.65 on September 25, 2026, with a daily high of $3.8 and a low of $3.52. These results were published as part of the company's quarterly regulatory reporting requirements to provide management commentary on its financial health.